DME Capital Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$130M Sell
4,400,641
-117,740
-3% -$3.02M 3.32% 5
2026
Q1
$106M Buy
4,518,381
+397,178
+10% +$7.19M 3.31% 7
2025
Q4
$58.5M Buy
4,121,203
+2,478,493
+151% +$46.9M 2.05% 15
2025
Q3
$40.7M Buy
1,642,710
+777,699
+90% +$17.4M 1.6% 19
2025
Q2
$19.6M Buy
865,011
+744,151
+616% +$17.6M 0.84% 21
2025
Q1
$3.66M Sell
120,860
-7,780
-6% -$296K 0.19% 26
2024
Q4
$5.1M Buy
+128,640
New +$5.8M 0.26% 25

Other funds holding ACHC

DME Capital Management's ACHC Position: Q2 2026 in Review

DME Capital Management reduced its Acadia Healthcare (ACHC) stake by 2.6% in Q2 2026, selling an estimated $3.02M and leaving 4,400,641 shares worth $130M. The position accounts for 3.32% of the portfolio, ranked #5.

DME Capital Management first reported a position in ACHC in Q4 2024 and has held it in 7 quarters since. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • DME Capital Management held 4,400,641 shares of Acadia Healthcare worth $130M as of Q2 2026.
  • DME Capital Management sold 117,740 Acadia Healthcare shares in Q2 2026, an estimated $3.02M.
  • Acadia Healthcare made up 3.32% of DME Capital Management's portfolio in Q2 2026, its #5 holding.
  • DME Capital Management first reported a position in Acadia Healthcare in Q4 2024 and has held it in 7 quarters since.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on DME Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.